Durable Clinical Response of Advanced Lung Adenocarcinoma Harboring EGFR-19del/T790M/BRAFV600E Mutations After Treating with Osimertinib and Dabrafenib Plus Trametinib: A Case Report
Honggang Ding,1,* Zhenjie Zhuang,1,* Jingyi Xie,1 Haifu Huang,2 Zhigang Tao,3 Zhanhua Liu4 1Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China; 2Shenzhen Hospital of Guangzhou University of Chinese Medicine, Shenzhen, People’s Republic of China; 3Myge...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-08-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/durable-clinical-response-of-advanced-lung-adenocarcinoma-harboring-eg-peer-reviewed-article-OTT |